“Global Endoscope Reprocessing Market to reach a market value of USD 2.8 Billion by 2031 growing at a CAGR of 9.0%”
The Global Endoscope Reprocessing Market size is expected to reach $2.8 billion by 2031, rising at a market growth of 9.0% CAGR during the forecast period.
There has been a steady increase in the number of endoscopic procedures performed in North America. This is due to factors such as an ageing population, which requires more diagnostic and therapeutic procedures, and advancements in endoscopic technology that make these procedures more accessible and effective. Regulatory bodies in North America, such as the FDA in the United States and Health Canada, have implemented strict guidelines for endoscope reprocessing to prevent healthcare-associated infections (HAIs). Thus, the North region acquired 39% revenue share in the market 2023.
Infections acquired by patients during the course of medical or surgical treatment constitute healthcare-associated infections (HAIs), which present a critical hazard to safety. The prevalence of HAIs has highlighted the urgent need for stringent infection control measures within healthcare settings.
Additionally, the ASP AEROFLEX AER uses a peracetic acid-based disinfectant, which is highly effective at low temperatures, ensuring thorough disinfection without damaging delicate endoscope components. Hence, technological advancements are aiding in the expansion of the market.
However, the initial investment required to purchase automated endoscope reprocessors (AERs), high-quality disinfectants, and other necessary accessories can be substantial. For instance, a single AER can cost tens of thousands of dollars, not including the additional expenses for installation, training, and integration with existing systems.
By end-use, the market is divided into hospitals and outpatient facilities. The hospitals segment garnered 44% revenue share in the market in 2023. Hospitals perform a large number and variety of medical procedures that require the use of endoscopes.
Based on product, the market is characterised by high-level disinfectants & test strips, detergents & wipes, automated endoscope reprocessors (AERs), endoscope drying, storage, & transport systems, and others. The high-level disinfectants and test strips segment garnered 29% revenue share in the market in 2023.
On the basis of automated endoscope reprocessors (AERs) type, the market is bifurcated into single basin and double basin. The single basin segment garnered 60% revenue share in the market in 2023. The segment's growth can be attributed to its cost-effectiveness, ease of use, and space-saving design.
By automated endoscope reprocessors (AERs) portability, the market is segmented into standalone AER and portable AER. The standalone AER segment garnered the 64% revenue share in the market in 2023. Its robust performance, reliability, and ability to handle high-volume reprocessing demands drive the growth.
Free Valuable Insights: Global Endoscope Reprocessing Market size to reach USD 2.8 Billion by 2031
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment acquired 29% revenue share in the market in 2023. In Europe, healthcare professionals and the general public are becoming more aware of the risks of improperly reprocessed endoscopes.
| Report Attribute | Details |
|---|---|
| Market size value in 2023 | USD 1.4 Billion |
| Market size forecast in 2031 | USD 2.8 Billion |
| Base Year | 2023 |
| Historical Period | 2020 to 2022 |
| Forecast Period | 2024 to 2031 |
| Revenue Growth Rate | CAGR of 9.0% from 2024 to 2031 |
| Number of Pages | 238 |
| Number of Tables | 428 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Product, End-use, Region |
| Country scope |
|
| Companies Included | Belimed AG (Metall Zug AG), ASP Global Manufacturing GmbH (FORTIVE CORPORATION), Ecolab, Inc., Getinge AB, Steelco S.p.A. (Miele Group), ARC Healthcare Solutions Inc., Metrex Research, LLC (Envista Holdings Corporation) and Shinva Medical Instrument Co., Ltd. |
By End-use
By Product
By Geography
This Market size is expected to reach $2.8 billion by 2031.
Growing awareness about infection control are driving the Market in coming years, however, High costs associated with advanced endoscope reprocessing equipment restraints the growth of the Market.
Belimed AG (Metall Zug AG), ASP Global Manufacturing GmbH (FORTIVE CORPORATION), Ecolab, Inc., Getinge AB, Steelco S.p.A. (Miele Group), ARC Healthcare Solutions Inc., Metrex Research, LLC (Envista Holdings Corporation) and Shinva Medical Instrument Co., Ltd.
The expected CAGR of this Market is 9.0% from 2024 to 2031.
The Outpatient Facilities market dominated the Market by End-use in 2023; thereby, achieving a market value of $1.4 billion by 2031.
The North America region dominated the Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1 billion by 2031.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 